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Abstract 
To address the question whether calretinin (CR) may protect cells against Ca 2+ overload or trophic factor deprivation, PC12 cells 
were transfected with plasmids containing a CR coding region under control of a cytomegalovirus promoter. Nerve growth factor (NGF) 
treatment induced differentiation, increased transfection efficiency (at least 10-fold) and activated the CR gene (as found by RNase 
protection method and immunohistochemistry). Exogenous CR expression was identified either in living cells by fluorescence of green 
fluorescent protein (when the CR coding region was fused to this protein) or in fixed cells by CR immunoreactivity. Undifferentiated and 
NGF-differentiated populations of transfected cells were incubated in the presence of a Ca2+-ionophore or in media deprived of serum or 
NGF. Expression of exogenous CR in undifferentiated or NGF-treated cells (due to transfection) or endogenous CR (due to gene 
activation by NGF) did not render PC12 cells more resistant to insults such as CaZ+-overload nd trophic factor deprivation. 
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1. Introduction 
Calretinin (CR), a calcium binding protein homologous 
to calbindin D28k, is present in subsets of brain neurons 
[1-3]. The role of this protein is unknown, but is believed 
to be related to CaZ+-binding [4,5] and to be similar to the 
function of calbindin D28k. Some possible CR and cal- 
bindin D28k functions are Ca 2+ buffering, Ca 2+ transport, 
and sensing changes of [Ca2+] i to alter the activity of 
target protein(s) (calmodulin-like activity). It has been 
shown that some neurons containing calbindin D28k are 
more likely to survive stressful or pathological conditions 
than neurons without calbindin D28k. It was suggested that 
the presence of calbindin D28k may protect neurons from 
calcium-mediated neurotoxicity [6-8]. However, other ac- 
tivities for calbindin D28k have not been excluded. 
We have shown that CR changes conformation upon 
Ca2+-binding in a manner characteristic for Ca2+-sensors 
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[9-12] and suggested that CR may possess a calmodulin- 
like activity. CR is substantially localized in particulate 
fractions of rat brain [13,14] suggesting that a portion of 
calretinin does not function as a mobile Ca 2 +-buffer. Oth- 
ers have shown that CR may protect some neurons against 
Ca 2 + and other insults and suggested that CR may act as a 
car -buf fer  [15,16]. The selective resistance of the CR 
immunoreactive population was very similar to that previ- 
ously shown for hippocampal neurons that contain cal- 
bindin D28k [17], and it has been suggested that the 
protective ffect is due to the Ca 2 +-buffering capacities of 
CR. However, some studies do not support he hypothesis 
that CR per se has a neuroprotective role [18,19] and it is 
possible that other factors are required for CR to act as a 
neuroprotective protein [15,16,18]. Studies in vivo also do 
not give a consistent picture with regard to CR function 
and possible neuroprotection [20-24]. 
The present studies were designed to clarify the issue 
and determine directly whether CR may protect cells 
against Ca 2+ overload and trophic factor deprivation. 
Properties of PC12 cells transfected with a plasmid con- 
taining a CR coding region were compared with those 
non-transfected cells or cells transfected with control vec- 
tors. Preliminary data indicated that CR does not make 
undifferentiated PCI2 cells more resistant o CaZ+-iono - 
phore (Ku~nicki, J., Strauss K.I., Isaacs, K.R. and Ja- 
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cobowitz D.M. (1995) Soc. Neurosci. Abstr. 21, p. 1129). 
This paper confirms and extends those observations sup- 
porting the hypothesis that CR does not provide protection 
per se and suggests that its function is not limited to 
CaZ+-binding. 
rescence was analyzed on an Olympus inverted micro- 
scope, and FITC or Texas Red fluorescence on a Leitz 
microscope. 
2.4. Transfection and immunohistochemistry 
2. Materials and methods 
2.1. Chemicals 
A23187 and poly-D-lysine were from Sigma. Nerve 
growth factor (NGF) (2.5S, Grade II) was from 
Boehringer-Mannheim; DMEM, horse serum, strepto- 
mycin/penicillin were from Gibco (Gaithersburg, MD); 
collagen from Collaborative Biomedical Products (Be- 
dford, MA). 
2.2. Cloning of plasmids with CR coding region 
The rat CR coding region was cloned between BamHI 
and EcoRI sites of a multiple cloning site in a pBK-CMV 
vector (Stratagene) to make pBK-CMV-CR. The prokary- 
otic promoter was removed (Nhel /Spel  cut), so that the 
CMV promoter was directly upstream of calretinin coding 
region (pBK-CMVACR vector). This allowed us to ex- 
press full length CR under the control of the CMV pro- 
moter in PCI2 cells. 
The rat CR coding region was also cloned in XhoI and 
BamHI sites in the vector pS65T-C1 (Clontech) containing 
a coding region of a Green Fluorescent Protein (GFP) 
under the control of the CMV promoter. The CR insert 
was created using a polymerase chain reaction (PCR, Gen 
Amp PCR System 9600, Perkin Elmer/Cetus) with the 
full-length CR coding region (pGEXCR) [25] as a template 
and Vent polymerase (New England BioLabs). Custom 
primers (Operon, California) were as follows: 5'CAG CT 
CTCGAG TC ATG GCT GGC CCG CAG CA (forward 
primer containing XhoI sites (in bold) and 5' end of CR 
coding region (italic), and 5'CGTG GGATCC TI'A CAT 
GGG GGG CTC ACT G (reverse primer containing BamHI 
site (in bold) and 3' end of CR coding region (italic). 
2.3. Cell culture and fluorescent microscopical observa- 
tion 
PC12 cells were either from ATCC, Rockville (called 
ATCC-2), from Dr. B. Wolozin, NIMH, Bethesda (W-9), 
or from Dr. C.Y. Gao, NEI, Bethesda (G-12). The fastest 
growing cells and fastest NGF-induced ifferentiation was 
observed with the latter cells and they were used for most 
experiments. PC12 cells were cultured in DMEM in the 
presence of 5% fetal bovine serum, 10% horse serum, and 
penicillin/streptomycin on Nunc 2-well slides coated with 
poly-D-lysine or collagen or on petri dishes without coat- 
ing. Media was changed every 2-3 days. Cells were 
treated for 2-10 days with NGF (100 ng/ml). GFP-fluo- 
Transfection was produced using either Lipofectamine 
or Cellfectin (Gibco) according to manufacturer's proto- 
cols. Serum was absent during transfection but in some 
experiments ransfection of undifferentiated cells was per- 
formed in the presence of NGF (100 ng/ml). Immunohis- 
tochemistry was used to evaluate the fate of transfected 
PC12 cells deprived of horse serum (undifferentiated), or 
deprived of NGF (differentiated with NGF) or treated with 
Ca 2 ÷ ionophore A23187 (both undifferentiated and differ- 
entiated). For immunofluorescent detection of CR, cells 
were fixed in 10% neutral buffered formalin (10 min), 
washed with PBS, and then immersed in a 0.3% Triton 
X-100 solution with goat CR antiserum (Winsky, L., Isaacs 
K.R. and Jacobowitz D.M. (1996) Brain Res., submitted) 
(1:5000) and 1% normal donkey serum for 48h at 4°C. 
Donkey anti-goat secondary antibodies conjugated with 
fluorescein (FITC) (1:300) or Texas Red (1:100) were 
used to visualize CR. Cells were stained with Hoechst 
33342 to label nuclei. Living cells transfected with GFP-CR 
appeared bright green in the inverted fluorescent micro- 
scope, but were fixed and immunoreacted with CR anti- 
bodies and Texas Red secondaries to confirm the presence 
of CR. Upon confirmation of a 1:1 correspondence of
CR:GFP in CR-GFP transfected cells, subsequent data 
analysis was performed on living fluorescent cells. 
2.5. Cell counting and statistics 
The number of CR-transfected cells (cells expressing 
CR due to transfection) per field was counted irectly from 
the microscope. At least 10 fields per slide well were 
counted. Photographs of Hoechst-stained nuclei from the 
fields containing CR-transfected cells were made and nu- 
clei were counted on a slide projector. ANOVA or two- 
tailed t-tests were calculated for all experiments and post- 
hoc Scheff6 analyses were used for specific comparisons 
when necessary. 
2.6. RNase protection method 
RNase protection assay was performed as described [26] 
using a calretinin riboprobe of 600 nucleotides. PC12 cells 
grown on 60 mm dishes and treated for 7 days with NGF 
(100 ng/ml) or cells grown in normal media for the same 
amount of time were dissolved in 0.2 ml 5 M guanidium 
thiocyanate (Fluka), and 0.13 M EDTA (pH 8.0). 
2.7. Treatment with calcium ionophore 
A 500 /zM stock of A23187 was dissolved in 100% 
ethanol. Undifferentiated cells were treated with 1 /xM 
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A23187 for 16 h followed by 3 /zM for 20 h (n = 9 wells) 
or with ethanol (n = 10 wells). In two separate experi- 
ments NGF-treated cells and control cells were exposed to 
1 /zM A23187 for 48 h then to 3 /zM 23187 for 24 h 
(n = 2 wells) or ethanol (n = 2 wells). 
2.8. Serum or NGF withdrawal 
24 h after transfection, undifferentiated cells were de- 
prived of horse serum for 24 h: no serum (n = 4 wells), 
control (n = 4 wells). 24 h after transfection, PC12 cells 
were treated with NGF (100 ng/ml)  for 5 days after which 
point NGF was removed from the medium (serum was 
present), (n = 6 wells), control (n = 3 wells). The cells 
were counted after 48 h of NGF withdrawal. 
3. Results 
3.1. Endogenous expression of CR in NGF-differentiated 
PC12 cells 
Expression of endogenous CR could not be detected in 
undifferentiated PC12 cells regardless of their origin by 
standard Westem blots or immunohistochemistry (not 
shown). After NGF-treatment of ATCC-2 and W-9 cells 
there was no signal for CR either by Western blot, im- 
munohistochemistry, or for CR mRNA by the RNase 
protection method. However, low CR immunoreactivity 
was detected in all G-12 cells treated with NGF (Fig. 1A, 
B) and mRNA was detected by the RNase protection 
method (Fig. 1C). These results indicate that endogenous 
CR expression can be induced in certain clones of PC12 
cells under appropriate conditions uch as NGF-treatment. 
The level of endogenous expression of CR in NGF-treated 
cells was much lower than the level of exogenous expres- 
sion of CR achieved by transfection (Fig. 1A). 
3.2. Expression of CR following transfection of PC12 cells 
To analyze the effect of CR's presence on the properties 
of PC12 cells, we transfected undifferentiated ATCC-2 or 
G-12 cells with plasmids containing the CR coding region. 
The most efficient means of transfection was an incubation 
of cells with DNA-Lipofectamine complexes (2 /xg of 
DNA, 8 /xl of Lipofectamine for 125,000 cel ls/2 well 
Nunc slide). Under such conditions the transfection effi- 
ciency of undifferentiated cells was at a maximum of 5%. 
Other liposomes uch as Cellfectin gave lower yields, and 
no transfection was accomplished using calcium phos- 
phate-DNA complexes (not shown). Exogenous expression 
of CR in undifferentiated cells was visible within 24 h, and 
was transient as few if any CR-transfected cells remained 
after 10 days. 
Transfection with pCMV-GFP-CR or pBK-CMV • CR 
produced CR expressing cells both in undifferentiated and 
NGF-treated PC l 2 cells. Transfection of NGF-treated cells, 
although successful in the short-term, resulted in signifi- 
cant cell death. As such, we transfected undifferentiated 
cells and then exposed them to NGF. CR-transfected cells 
could be identified either by detecting GFP fluorescence in
living cells (GFP-CR ÷) (Fig. 2D, E, and F), or by CR-im- 
munoreactivity in fixed cells (Fig. 2B, and C). All GFP 
fluorescent cells were positive for CR (Fig. 2A, B). This 
figure also shows that GFP fluorescence can be seen after 
fixation (Fig. 2A) and simultaneously with CR-antibodies 
conjugated with Texas Red (Fig. 2B). 
Undifferentiated CR transfected cells were able to di- 
vide in the presence of serum (Fig. 2C), and to differenti- 
ate in the presence of NGF (Fig. 2F). In cells not express- 
ing GFP-CR, differentiation was detected as early as 24 h 
after the addition of NGF, and was seen in majority of 
cells after 7 days of NGF-treatment. GFP-CR-transfected 
cells differentiated after 7 days (Fig. 2D, F). The differen- 
tiation of GFP-CR cells appeared to be slower, but no 
Fig. 1. Endogenous expression ofcalretinin i  transfected and NGF-differentiated G-12 cells. A, B, fixed cells were incubated with calretinin antibodies 
and secondary antibodies conjugated with Texas Red. A: CR-imrnunoreactivity in cells treated with 100 ng/ml NGF for 3 days; arrow points to a 
transfected cell expressing exogenous CR, note the more intense fluorescence; B: CR-immunoreactivity is induced in cells treated with 100 ng/ml NGF 
for 6 days. Note all cells are CR positive in both the cytoplasm and nucleus, no CR-transfected cell in this view; C: RNase protection method, 
autoradiograph of the polyacrylamide g lshows the presence of calretinin mRNA in NGF-treated cells for 7 days (5,6), but not in initial PC12 cells 
extracts (3.4); 1, cerebellum extract as a control, 2, nulle control. Measurement bar for A and B = 57/z. 
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Fig. 2. PC 12 cells transfected with pCMV-GFP-CR (G-12) or pBK-CMV • CR (ATCC-2) yield CR-transfected cells. The cells can be identified either by 
detecting GFP fluorescence of living cells (Fig. 2D, E, F) in case of pCMV-GFP-CR plasmid, or in fixed cells by immunoreactivity as shown for both 
plasmids (Fig. 2A, B, C). A, B, C: Transfected, fixed, undifferentiated cells; Arrows point to transfected cells. A: GFP-fluorescence, B: same field as A, 
antibodies to CR (conjugated to Texas Red) label GFP-CR + cells; C: antibodies to CR (conjugated with FITC) reveal that CR-transfected cells can divide. 
D, E, F: transfected living, NGF-treated cells (2D = 2 days, 2E = 3 days, 2F, 7 days NGF exposure). Note many CR-transfected cells fail to differentiate in 
the early days of NGF-treatment although untransfected cells in the same dish are clearly differentiated. Measurement bar A,B = 50 /~; C = 65 ~; 
D,E,F = 57/x. 
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quantification of these observations was performed, and it 
is not known if it was an effect due to CR presence or due 
to transfection itself. 
3.3. Effect of NGF on transfection efficiency 
An interesting observation was made when cells trans- 
fected with pCMV-GFP-CR were subsequently treated with 
NGF. It was found that the number of GFP-CR + cells was 
increased after 24 h of NGF treatment and reached a peak 
of about a 24-fold increase after 5 days of NGF treatment 
(Fig. 3A). Observation of Hoechst blue-stained nuclei 2-3 
days after NGF-treatment did not reveal an increase in the 
number of mitotic CR-transfected cells over total popula- 
tion cell levels. In fact, as shown in Fig. 3B the number of 
GFP-CR + cells in the non-treated culture remained at the 
same level. The increased number of transfected cells 
cannot be attributed to the presence of CR since it was also 
seen in control cells transfected with pCMV-GFP plasmid. 
Therefore, the increased number of cells expressing GFP- 
CR or GFP seems to be due to the effect of NGF on the 
expression and/or stabilization of the plasmids used for 
transfection. Most if not all GFP-CR + cells can be still 
detected after 10 days in the presence of NGF, in contrast 
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Fig. 3. Effect of NGF on transfection efficiency of PC!2 cells (G-12). A: 
24 h after transfection with pCMV-GFP-CR, undifferentiated cells were 
incubated with NGF (100 ng/ml) and transfectants were identified by 
their GFP-fluorescence. The results are expressed as the ratio of number 
of GFP-CR + cells per field in NGF-treated culture versus number of 
GFP-CR- cells per field in non-treated culture. Control (n = 26 wells), 
12 h (n = 5 wells), 24 h (n = 4 wells), 48 h (n = 5 wells), 72 h (n = 4 
wells). 120 h (n = 6 wells). * P < 0.05; * * P < 0.01). B: data from a 
single experiment showing that the actual number of untreated GFP-CR + 
cells remained constant over time (dark area), while the number of 
GFP-CR + cells in NGF-treated culture (light area) increased (* P < 
0.05); Control, (n = 4 wells), 12 h treatment (n = 5 wells), 48 h treatment 
(n = 5 wells). 
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Fig. 4. Effects of Ca2+-ionophore on CR-transfected cells and the total 
population. Undifferentiated PC12 cells (ATCC-2) were treated with 1 
/xM of A23187 for 20h +3 /~M for 16 h. CR-transfected cells were 
identified by immunoreactivity of fixed cells. Total number of undifferen- 
tiated control cells was 672 per field, and CR-positive cells - 2 per field. 
PC12 cells (G-12) were incubated with NGF (100 ng/ml) for 5 days and 
then treated with ! /xM A23187 for 48 h +3 /.LM for 24 h in the 
presence of NGF. CR-transfected NGF-treated cells were identified by 
GFP fluorescence of living cells. Total number of NGF-treated control 
cells was 25 per field, and CR-positive cells - 8 per field. Note that in 
neither undifferentiated or differentiated was there a discrimination be- 
tween rate of loss of transfected and the total population of cells. 
to cells which were cultured for the same period of time in 
the absence of NGF. 
3.4. CR-transfected cells are not protected from calcium 
overload 
Populations of transfected PC12 cells (ATCC-2) were 
treated with Ca =+-ionophore (A23187). Undifferentiated 
CR-transfected cells were identified by immunoreactivity 
of fixed cells. In the presence of the drug cells expressing 
CR died at a similar rate and to a similar extent as the total 
population assessed in the same dish or well (Fig. 4). After 
treatment of undifferentiated PC12 cells about 70% of 
CR-transfected cells and 63.4% of CR-negative died. 
NGF-treated CR-positive cells were identified by GFP- 
CR fluorescence of living PC12 cells (G-12) and their 
survival was compared to other cells in the same culture. 
NGF-treated CR-transfected cells were sensitive to A23187 
similarly to cells which did not express exogenous CR due 
to transfection (Fig. 4). This indicates that CR overexpres- 
sion does not make PC12 cells more resistant o Ca 2+ 
overload and regardless of their differentiation status, they 
are similarly sensitive to this ion. It should be pointed out 
that all NGF-treated cells expressed low level of endoge- 
nous CR (see Fig. 1), and that the presence of this endoge- 
nous CR did not make them resistant to Ca 2+ overload. 
3.5. CR-expressing cells are not protected against serum 
or NGF withdrawal 
CR-positive cells were identified by GFP-CR fluores- 
cence of living PC12 cells (G-12). Populations of trans- 
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Fig. 5. Effects of serum or NGF withdrawal on CR-transfected (CR + ) 
and on total population of PC12 cells. 24 h after transfection, serum was 
withdrawn from undifferentiated PC12 cells (G-12) for 24 h. PCI2 cells 
(G-12) were incubated 24 h after transfection with NGF (100 ng/ml) for 
5 days, and then NGF was withdrawn for 48 h. CR-transfected cells were 
identified by GFP fluorescence of living cells. As in Fig. 4 no difference 
between CR-transfected cells aad the total population was detected. 
* * P < 0.01 compared with untreated wells. Total number of undifferen- 
tiated control cells was 165 per field, and CR-positive cells - 4 per field 
in the experiment with serum deprivation, and 130 and 20, respectively in
the experiment with NGF depriwation. 
fected, undifferentiated PC 12 cells were deprived of serum 
for 24 h and the remaining CR-transfected and CR-nega- 
tive cells were counted in the same dish or well. The 
extent of death after serum deprivation was similar for 
both types of cells 59.3% vs. 51.1%, respectively (Fig. 5). 
These observations how that CR's presence does not 
change the sensitivity of PC12 cells to serum deprivation. 
Similar experiments were conducted using the popula- 
tion of transfected and then NGF-treated cells. As men- 
tioned in Section 3.1 and shown in Fig. 1 low CR 
immunoreactivity was induced in all PC12 cells (clone 
G-12). Their survival was compared with cells, in the same 
dish or well, which expressed exogenous CR due to trans- 
fection. NGF-deprivation for 48 h (after 5-6 days pretreat- 
ment with NGF) induced death in about 50% GFP-CR + 
cells versus 40% of the cells not expressing GFP-CR (Fig. 
5). 
4. Discussion 
We report that endogenous CR expression can be de- 
tected in PC12 cells after activation of the CR gene, but 
only in certain cell lines. For instance, NGF-treatment 
activated endogenous expression of CR in PCI2 cells 
obtained from one source, but not in PC12 cells obtained 
from two other sources. The reason for the different behav- 
ior of subclones of PC12 cells is not clear, but it may be 
due to the overall responsiveness of these cells to NGF. In 
the cells most sensitive to NGF, differentiation was visible 
in many cells after 24 h treatment, and in these cells CR 
expression could be detected. This was not the case with 
the other two subclones of PC12 cells. Differentiation 
itself does not seem to be a necessary step for induction of 
CR gene since other factors may activate this gene without 
inducing differentiation (Isaacs, Kulnicki, Jacobowitz, in 
preparation). The ability to induce endogenous expression 
of CR in PC12 cells provides an interesting model to study 
the effect of CR on the properties of these cells. However, 
low levels of endogenous CR and the necessity to induce 
its expression make some studies difficult to perform. It is 
difficult to estimate the level of CR after NGF-treatment of
PC12 cells, but judging from the intensity of immuno- 
reactivity it is much lower than that in the granule cells of 
cerebellum or in neurons present in some brain nuclei. 
Also, it is much lower than the level of exogenous CR 
achieved as a result of transfection. It has been estimated 
that the level of calbindin D28k in Purkinje cells of 
cerebellum is about 50 fg per cell [27]. This value has been 
extrapolated by comparison to estimate that the cellular 
content of calbindin D28k is about 10 fg per granule cells 
in the hippocampal dentate gyrus, and about 5 fg in 
cultured human SH-SY-5Y neuroblastoma cells [28]. CR 
content has not been established for any ceils and we can 
only speculate that in neurons it might be in a similar 
range to that of calbindin D28k. 
An unexpected observation from this work is related to 
the use of NGF as a factor which increases transfection 
efficiency and prolongs protein expression encoded by the 
plasmids used. At least a 10-fold increase in transfection 
efficiency, and in some experiments a 50-fold enhance- 
ment was observed when NGF was added during or shortly 
after transfection. This effect was not related to the pres- 
ence of CR since an enhanced transfection with the plas- 
mid containing GFP only was also similarly induced by 
NGF. It is unlikely that this phenomenon is due to the loss 
of the expression plasmid during the division of undiffer- 
entiated cells for the following reasons: the number of 
untreated GFP-CR cells remains constant over the days, 
whereas the number of NGF-treated GFP-CR cells steadily 
increases, equal strong fluorescence is observed in both 
daughter cells, the several fold increase in number of 
GFP-CR cells observed within 24 h after NGF addition is 
too large to be explained by the difference in the rate of 
divisions. Among several possible explanations for this 
phenomenon one is that it may be related to the effects of 
NGF on overall metabolism of PC12 cells, which may 
indirectly activate the cytomegaloviral promoter. If so, it 
may not have a major physiological significance, but the 
use of NGF to increase transfection efficiency, and the 
expression of proteins encoded by a variety of plasmids, 
may become a useful method in other studies. The possi- 
bility exists that there are other factors, which while 
affecting metabolism of cultured cells, may also be used to 
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increase transfection efficiencies. If so, the methods of 
transient expression of proteins for experimental nd thera- 
peutic uses can be significantly improved. 
To address the question of whether exogenous expres- 
sion of CR makes PC12 cells more resistant o Ca 2+ 
overload and trophic factor deprivation, cells were trans- 
fected with the plasmids containing the CR coding region 
under a CMV promoter which is highly active in PC12 
cells. The direct comparison of survival of ATCC-2 and 
W-9 clones which seem not to express CR after NGF 
treatment with the survival of G-12 clone was not possible 
because of difference in the culture conditions such as 
coating. 
Serum deprivation of undifferentiated PC I2 cells or 
NGF withdrawal from NGF-treated cells have been known 
to induce detachment and cell death [29,30]. Our experi- 
ments with trophic factor withdrawal indicate that both 
transfected cells with high level of a calcium-binding 
protein (CR) or NGF-treated cells with low level of en- 
dogenous CR are not protected against such stress. There- 
fore, we believe that CR alone cannot help cells to survive 
in vivo under pathological conditions. However, CR seems 
to protect cells against HIV pgl20 toxicity [31]. Treatment 
of the undifferentiated or NGF-treated cells with Ca 2+- 
ionophore for at least 20 h induced death of both the 
CR-transfected and the total population of cells similarly. 
This indicates the overexpression f CR did not help the 
cells to cope with the Ca 2+ overload, and did not protect 
them against Ca 2÷ insult. It has been shown (Fellay, 
Schwaller, Schneider, Gotzos and Celio, Abstracts of 
Fourth European Symposium on Calcium Binding Pro- 
teins, Perugia 1996, p. 49) that a protective ffect of CR 
can be observed within the first hour following excitatory 
amino acids stimulation of P19 cells. However, this protec- 
tion was transient and failed to protect P19 cells after 
prolonged stress. They also showed that the capacity to 
reduce [Ca 2+ ]i after excitatory amino acids was increased 
in cells expressing CR. These data indicate that CR is 
capable to buffer changes of Ca e÷ and thereby to protect 
nerve cells, but only during initial raise of Ca 2+. Both, our 
work (this paper) and that of Fellay et al. (1996) indicate 
that CR cannot protect cells during prolonged exposure to 
Ca 2+ overload. We believe that those results do not sup- 
port the hypothesis that CR may protect neurons in vivo 
under prolonged pathological overstimulation a d resulting 
disturbances in the calcium homeostasis. Although CR is 
able to buffer Ca 2+, it seems not able to provide long 
lasting protection, and it is possible that additional factors 
may be involved in creating a protection of CR-positive 
neurons described by other authors [15,16,18]. If this is 
true, a search for CR targets is justified. 
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